Saturn V Capital Management LP
CIK 1964437
13F filing for Q2 2026・No. 3,220
- Holdings
- US$697.47M
- Quarter change
- +US$145.25M
- Entries
- 23
- Net bought (estimate)
- +US$44.91M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 3
- Sold out 1
- Cut 6
- Added 13
- Corporate actions 0
- Unchanged 1
Largest holdings
23 stocks worth US$697.47M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| AMYLYX PHARMACEUTICALS INCCOM | Added | 4,624,101 | US$83.05M | 11.91% |
| ALUMIS INCCOM | Cut | 2,915,443 | US$82.04M | 11.76% |
| ABIVAX SASPONSORED ADS | Cut | 518,865 | US$69.14M | 9.91% |
| PCVXVAXCYTE INCCOM | Added | 852,914 | US$49.58M | 7.11% |
| IMMIX BIOPHARMA INCCOM | Added | 4,658,429 | US$48.03M | 6.89% |
| PHARVARIS N VCOM | Added | 1,314,122 | US$45.44M | 6.52% |
| JAZZJAZZ PHARMACEUTICALS PLCSHS USD | Cut | 160,938 | US$38.78M | 5.56% |
| CELCUITY INCCOM | Added | 370,318 | US$38.74M | 5.55% |
| DISC MEDICINE INCCOM | Added | 524,730 | US$38.38M | 5.50% |
| CANDEL THERAPEUTICS INCCOM | Added | 3,303,686 | US$34.03M | 4.88% |
Sign in (free) to see its 23 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.